Search

Author/Creator Baratta, Mike

1. Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases. Issue 7 (16th December 2020)

Authors:
Sun, Wan; Lirio, Richard A.; Schneider, Jennifer; Aubrecht, Jiri; Kadali, Harisha; Baratta, Mike; Gulati, Parul; Suri, Ajit; Lin, Tiffany; Vasudevan, Raghavan; Rosario, Maria
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 7(2021)
Page Start:
734
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S0876 Assessment of Vedolizumab Disease-Drug-Drug Interaction in Patients With Inflammatory Bowel Diseases. (October 2020)

Authors:
Sun, Wan; Lirio, Richard A.; Schneider, Jennifer; Aubrecht, Jiri; Kadali, Harisha; Baratta, Mike; Gulati, Parul; Suri, Ajit; Lin, Tiffany; Vasudevan, Raghavan; Rosario, Maria
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1
Page Start:
S451
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative Bioavailability of 2 Capsule Products. Issue 9 (12th June 2021)

Authors:
Zhang, Steven; Jin, Shu; Griffin, Celina; Feng, Zhongling; Lin, Jianchang; Baratta, Mike; Brake, Rachael; Venkatakrishnan, Karthik; Gupta, Neeraj
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 9(2021)
Page Start:
1028
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗